Increased Risk of Cerebrovascular Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis

PLoS ONE - United States
doi 10.1371/journal.pone.0102484
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

No Evidence of Increased Risk of Malignancies in Patients With Diabetes Treated With Insulin Detemir: A Meta-Analysis

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Bevacizumab-Based Chemotherapy and Thrombotic Events Risk in Colorectal Cancer Patients: A Meta-Analysis Study of Randomized Controlled Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Increased Risk of Severe Infections in Cancer Patients Treated With Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2015English

Incidence and Relative Risk of Peripheral Neuropathy in Cancer Patients Treated With Eribulin: A Meta-Analysis

Oncotarget
Oncology
2017English

The Incidence and Relative Risk of Adverse Events in Patients Treated With Bisphosphonate Therapy for Breast Cancer: A Systematic Review and Meta-Analysis

Therapeutic Advances in Medical Oncology
Oncology
2019English

Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events

Journal of the American College of Cardiology
Cardiovascular MedicineCardiology
2003English

Mortality After a Cerebrovascular Event in Age-Related Macular Degeneration Patients Treated With Bevacizumab Ocular Injections

Acta Ophthalmologica
MedicineOphthalmology
2018English

Bevacizumab Improves Survival in Metastatic Colorectal Cancer Patients With Primary Tumor Resection: A Meta-Analysis

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy